Poniard Pharmaceuticals, Inc.

PARD · OTC
Analyze with AI
12/31/2010
12/31/2009
12/31/2008
12/31/2007
Operating Activities
Net Income-$30-$46-$49-$33
Dep. & Amort.$1$1$2$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$9$7$7$0
Change in WC-$7-$3$6$2
Other Non-Cash$2$4$0$5
Operating Cash Flow-$24-$35-$33-$25
Investing Activities
PP&E Inv.-$0-$0-$0-$6
Net Acquisitions$0$0$0$0
Inv. Purchases-$7-$53-$46-$104
Inv. Sales/Matur.$31$54$81$52
Other Inv. Act.$0$0$0$3
Investing Cash Flow$24$1$34-$56
Financing Activities
Debt Repay.-$20-$8$14-$4
Stock Issued$6$15$0$70
Stock Repurch.-$0-$1-$1$0
Dividends Paid$0-$1-$1-$1
Other Fin. Act.-$0$0-$0-$0
Financing Cash Flow-$14$6$14$65
Forex Effect$0$0$0$0
Net Chg. in Cash-$15-$28$15-$15
Supplemental Information
Beg. Cash$16$44$29$44
End Cash$1$16$44$29
Free Cash Flow-$24-$36-$34-$30
Poniard Pharmaceuticals, Inc. (PARD) Financial Statements & Key Stats | AlphaPilot